Low fluence rate photodynamic therapy combined with intravitreal bevacizumab for neovascular age related macular degeneration.

Ciro Costagliola (1) , Mario R Romano (1) , Michele Rinaldi (2) , Robeto Dell'Omo (1) , Flavia Chiosi (2) , Massimo Menzione (2) , Francesco Semeraro (3)

1 UNIMOL - Università degli Studi del Molise = University of Molise
2 University of Naples Federico II = Università degli studi di Napoli Federico II
3 UniBs - Università degli Studi di Brescia = University of Brescia

to report efficacy and safety of intravitreal bevacizumab (IVB) alone versus IVB plus low fluence PDT in age-related macular degeneration (AMD) patients and to verify the occurrence of a synergistic effect of the combined approach on visual acuity, size and morphology of lesion, as well as on the treatment rate.

Mots clés: Retina; Neovascularisation; Treatment Lasers

Ciro Costagliola, Mario R Romano, Michele Rinaldi, Robeto Dell'Omo, Flavia Chiosi, et al.. Low fluence rate photodynamic therapy combined with intravitreal bevacizumab for neovascular age related macular degeneration.. British Journal of Ophthalmology, 2010, 94 (2), pp.180-n/a. ⟨10.1136/bjo.2009.159343⟩. ⟨hal-00508659⟩